How much funding has Ventus Tx raised?

Ventus Tx has raised $300.0M in total funding, most recently a Series C round.

Where is Ventus Tx headquartered?

Ventus Tx is headquartered in Waltham, Massachusetts, United States.

How many employees does Ventus Tx have?

Ventus Tx has 51-200 employees.

Ventus Tx

Q: Who are Ventus Tx's investors?

Ventus Tx's investors include SoftBank, RA Capital Management, Jerel Davis, GV.

Creating exceptional medicines with structure and ReSOLVE

Waltham, United States · Founded 2020 · $300.0M raised

Biotech

Headquarters: Waltham, Massachusetts
Employees: 51–200
Founded: 2020
Business Model: B2B

Total Funding: $300.0M
Last Round: $140.0M Series CFeb 2022
Rounds: 3

About

Ventus Therapeutics is a clinical-stage biopharmaceutical company using structural immunology and its proprietary ReSOLVE platform to discover and develop novel small-molecule medicines targeting the innate immune system. Founded in 2020 by Versant Ventures with co-founders from Harvard Medical School, Ventus has advanced multiple lead programs from target screening to Phase 2 clinical trials, including VENT-02 for Parkinson's disease and VENT-03 for lupus. The company integrates structural biology with immunology to identify pockets in innate immune targets such as NLRP3 and cGAS, with the goal of creating breakthrough therapies for diseases where the innate immune system plays a central pathological role.

Summary

Ventus Tx is a Biotech company based in Waltham, United States, founded in 2020. It has raised $300.0M in total across 3 rounds, most recently a $140.0M Series C round in Feb 2022. Investors include SoftBank, RA Capital Management and Jerel Davis.